Navigation Links
Genitourinary in Medical News

Blood transfusion study: Less is more

...100 percent, and blood use among men varied from about 50 percent to 100 percent. Transfusions with donor blood were associated with infections of the genitourinary system, respiratory tract, bloodstream, digestive tract and skin, the study said. The risk of death in the hospital was nearly 5 times greater amon...

Combination Therapy Best for Aggressive Prostate Cancer

...idence supporting this treatment method alone based on survival data from randomized trials is lacking," lead researcher Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston, said in a news release from the hospital. "In order to get the highest cure rate for ...

MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009

...e than 43,000 cancer treaters globally and covers all major and smaller oncology areas, including lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, hematological malignancies, and melanoma. MDOUTLOOK is being launched in other complex diseases, such as Rheumatoid Arth...

BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

...ocial/Social_Trends38/ST38_Ch07.pdf 3 Health Protection Agency. (2007, July, 20). Sexually transmitted infection diagnoses and services provided in genitourinary medicine clinics in the country-region in 2006. Retrieved January 5, 2009 from http://www.hpa.org.uk/hpr/archives/2007/news2007/news2907.htm 4 Ind...

Gene Test Helps Detect Prostate Cancer

... could spare tens of thousands of men from undergoing an unnecessary biopsy," study author Dr. William K. Oh, clinical director of the Lank Center for genitourinary Oncology at the Dana-Farber Cancer Institute in Boston, said in a news release from the organization. "However, until we can verify our findings, i...

New blood test greatly reduces false-positives in prostate cancer screening

...st results underscores the need for a more accurate method for detecting prostate cancer, said Oh, who is the clinical director of the Lank Center for genitourinary Oncology at Dana-Farber. The two-year study involved 484 participants. The group comprised 204 men with known prostate cancer, 110 men with benign ...

Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer

...ombination with docetaxel and prednisone is active as first-line therapy for CPRC," said William K. Oh, M.D., clinical director of the Lank Center for genitourinary Oncology at the Dana Farber Cancer Institute and associate professor, Harvard Medical School . "There is no platinum-based chemotherapy approved for ...

Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting

...ASCO) Annual Meeting in Orlando, Fla. Oral Abstract Session: genitourinary (Prostate) Cancer Abstract Title: "Antitumor Activity of MD...Scher, principal investigator, chief of the genitourinary Oncology Service and the D. Wayne Calloway ...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)

...aspirin, warfarin or other drugs that affect coagulation. Male patients with a history of obstructive uropathies may experience higher rates of genitourinary adverse events. Savella is unlikely to be involved in clinically significant pharmacokinetic drug interactions. Pharmacodynamic interactions of ...

Drug shows activity in men with advanced prostate cancer

...ts who received the drug at higher doses were recently reported at the ASCO genitourinary Cancers Symposium in February 2009 (see abstract: http://www.asco.org/ASCO...are encouraging," said Howard Scher, MD, a study co-author and Chief of the genitourinary Oncology Service at MSKCC. "I am looking forward to continuing the study of...
Genitourinary in Medical Technology

Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium

BRISBANE, Australia, Feb. 13 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced positive preliminary efficacy results from a phase 2 investigator-initiated trial of PI-88 in combination with the chemotherapeutic agent Taxotere(R) (docetaxel) admin...

Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

...viving on average a year or less -- with no approved treatment options," said Howard Scher, M.D., principal investigator of the trial and chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York. "These findings suggest t...

Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer

...leveland Clinic Taussig Cancer Institute, in a poster discussion during the genitourinary Cancer session. The study enrolled a total of 50 patients, of which 4...a, Principal Investigator Nicholas Vogelzang, MD, Professor and Head of the genitourinary Cancer Program at the Nevada Cancer Institute, stated, "perifosine demonstr...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

...patients with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC) during the American Society of Clinical Oncology (ASCO) 2009 genitourinary Cancers Symposium. Efficacy results to date showed reductions in prostate specific antigen (PSA) levels of at least 50 percent were achieved in 78 per...

Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer

... - Data presented today at American Society of Clinical Oncology (ASCO) genitourinary Cancers Symposium - MALVERN, Pa., Feb. 27 /PRNewswire/ -- Ascenta Ther... prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) genitourinary Cancers Symposium in Orlando, FL. AT-101, an oral, pan-Bcl-2 inhibitor cur...

Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting

...of MDV3100 in patients (pts) with progressive Castration-Resistant Prostate Cancer (CRPC)" by principal investigator, Howard Scher, M.D., chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York. The ongoing Phase 1-2 t...

US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings

...comparison of gemcitabine/oxaliplatin versus paclitaxel/carboplatin as first-line therapy for advanced non-small cell lung cancer (NSCLC) genitourinary -- Guru Sonpavde, M.D., Texas Oncology-Deke Slayton Cancer Center: Phase II study of Azacitidine for castration-resistant prostate cancer ...

Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting

...3100 in Patients with Progressive Castration-Resistant Prostate Cancer (CRPC)" (Abstract #5006) To be presented by: Howard Scher, M.D., chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York, at approximately 12:15 ...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

...GVAX immunotherapy for prostate cancer and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC)" (Abstract #5146, genitourinary Cancer Session) -- Poster presentation from 8:00 a.m. to 12:00 p.m. local time on Saturday, May 31, 2008. Clinical and Preclinical Data of A...

Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients

... - Poster Presented at ASCO genitourinary Cancers Satellite Symposium - SOUTH SAN FRANCISCO, Calif., Feb. 15 /PRNew...se 1 study of picoplatin, the Company's lead product candidate, at the 2008 genitourinary (GU) Cancers Symposium, a meeting of the American Society of Clinical Oncol...
Genitourinary in Medical Dictionary

Genitourinary system

... In anatomy, the genitourinary system or urogenital system is the organ s...ays, like the male urethra. The Body > The genitourinary System ... like a plumbing system , with special pipes that ... Find out more about the genitourinary system . Articles: The Bladder ... Trauma of...

Blood in the semen

... does a doctor confirm that it is blood that is in the semen ? ... Blood in semen can be caused by many conditions affecting the male genitourinary ... Blood in the semen is most commonly a result of a prostate-gland biopsy. ... Blood in the Semen ( Blood in Ejaculation, Se...

BCG

... BCG gained FDA approval. ... Welcome to BCG Oncology, the Phoenix, AZ practice of Donald L. Lamm, MD, leading expert in bladder cancer and genitourinary oncology. BCG (Bacillus Calmette-Guerin) is a biologic response modifier. ... BCG is given by intravesicular infusion. ... The BCG solution ...
Genitourinary in Biological News

New drug shows promise in treating drug-resistant prostate cancer

...begin what Jung described as "the pivotal Phase 3 clinical trials." The results of clinical studies with MDV3100 were described at the 2009 ASCO genitourinary Cancer Symposium in February by the trials' principal investigator, Dr. Howard Scher of Memorial Sloan-Kettering Cancer Center. In general, the drug, ...

UF scientist tapped by Howard Hughes Medical Institute to pursue 'best ideas'

...d cellular processes that take place in external genitalia development, like outgrowth and closure of the urethral tube," Cohn said. "The incidence of genitourinary malformations in humans came as a huge surprise to me. A staggeringly high frequency of one in 250 kids has a urethral tube defect, and that number ha...

Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test

...am K. Oh, M.D., clinical director, Lank Center for genitourinary Oncology, DFCI today presented the data from abstr...on at the American Society for Clinical Oncology's genitourinary Cancers Symposium. The study was co-investigated .... Ross, M.D., attending physician, Lank Center for genitourinary Oncology, DFCI. The PCCTC, a national clinical ...

UCLA/VA partners with ASU to advance biosensor technology for urinary tract infections

...hysicians have pioneered treatments for many conditions, including cancers of the prostate, bladder and kidney; kidney stones; pelvic floor disorders; genitourinary tract conditions; incontinence; and sexual dysfunction in men and women. The Biodesign Institute at Arizona State University is focused on innova...

More kidney cancer is detected and treated early, yet death rate rises

...here are some patients with small kidney tumors for whom surgery is not the best option." Kidney cancer is the third most common malignancy of the genitourinary system (the reproductive system and urinary system). The American Cancer Society estimates there will be about 38,890 new cases of kidney cancer (24,6...
Genitourinary in Biological Technology

AEterna Zentaris Presents Data Supporting Evaluation of AEZS-108 in Prostate Cancer at ASCO Meeting

...ter prolonged use of LHRH agonists; these data provide further support to the investigation of AEZS-108 in hormone-refractory prostate cancer, a major genitourinary cancer indication in male patients." Results LHRH receptor expression was demonstrated in more than 95% of 130 prostate cancer specimens ana...

AEterna Zentaris to Present Data Supporting Evaluation of AEZS-108 in Prostate Cancer at Upcoming ASCO Meeting

...he investigation of the drug in hormone-refractory prostate cancer, a major genitourinary cancer indication in male patients. Abstract selected for presentation is as follows: genitourinary Cancer Sunday, May 31, 2009: # 5103: Expression of LHRH receptors in...

The Arcas Group Appoints Executive Vice President

...r treaters in North America and Europe and covers all major and smaller oncology areas, including lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, hematological malignancies and melanoma. MDOUTLOOK will be launched shortly in other complex diseases, such as Ophthalmology, Parkinson's Dise...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

...h metastatic castration resistant prostate cancer (mCRPC)" (Abstract #5138, genitourinary Cancer - Prostate Session) S. Slovin - General poster from 2:00 p.m. to 6:0...h metastatic castration-resistant prostate cancer (mCRPC)" (Abstract #5144, genitourinary Cancer Session) M. Mohebtash - General poster from 2:00 p.m. to 6:00 p.m. l...

Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009

...ta presented at international cancer symposium In February 2009, data on PROSTVAC(TM) were presented at the international cancer congress, 2009 genitourinary Cancers Symposium in Orlando, Florida. The data from three different studies once again confirm the excellent safety and efficacy results previously r...

Bavarian Nordic Publishes its Annual Results 2008

...M) - further data presented In February 2009, the first detailed data on PROSTVAC(TM) were presented at the international cancer congress, 2009 genitourinary Cancers Symposium in Orlando, Florida. The data from three different studies once again confirms the excellent safety and efficacy results prev...

Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update

...escalation trial in patients with castration-resistant prostate cancer (CRPC). Presented data from our Phase 1-2 clinical trial at ASCO's 2009 genitourinary Cancers Symposium showing that MDV3100 consistently demonstrated encouraging anti-tumor activity across dose levels, endpoints and in both pre- and po...

Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

...ients - - Data To Be Presented at ASCO's 2009 genitourinary Cancers Symposium - - Medivation to Host Conf...incipal investigator of the trial and chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair i...merican Society of Clinical Oncology's (ASCO) 2009 genitourinary Cancers Symposium in Orlando, Fla. Teleconfe...

Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer

...t the American Society of Clinical Oncology's 2009 genitourinary Cancers Symposium - SOUTH SAN FRANCISCO, Cali...Oh, M.D., clinical director of the Lank Center for genitourinary Oncology at the Dana Farber Cancer Institute and a...merican Society of Clinical Oncology's (ASCO) 2009 genitourinary Cancers Symposium in Orlando, Fla. Picoplatin, the...

BN ImmunoTherapeutics Reports Further Data on PROSTVAC(TM)

...NIH) is now available. The data, that once again confirms the excellent safety and efficacy results previously reported, will be presented at the 2009 genitourinary Cancers Symposium (GU) on February 26-28, 2009 in Orlando, Florida. Abstracts from three different studies, where PROSTVAC(TM) has been evaluat...
Other Tags
(Date:8/20/2014)... A common approach to treating kidney failure ... improve survival chances for people who suddenly developed the ... University of Pittsburgh School of Medicine. ... PLOS One , suggest acute hemodialysis, an aggressive ... kidney failure, may not provide a definitive benefit to ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Quincy Bioscience, ... Inc. 500|5000 list of the fastest growing private ... year. Ranking at No. 2,941, Quincy Bioscience is honored ... in the United States. , Quincy Bioscience is manufacturer ... apoaequorin – a protein originally discovered in jellyfish and ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The non-small ... increase considerably in the offing across the top 8 ... of 2013 to around USD 8 billion by 2020-end, ... The growth is projected to be driven by innovative ... is currently lacking efficient treatment, unlike the non-squamous segment. ...
(Date:8/20/2014)... By Steven Reinberg ... -- A rare birth disorder that dismantles a baby,s immune ... study of more than 3 million infants says. This ... for the life-threatening but treatable condition known as severe combined ... "People were made aware of this condition by the boy ...
(Date:8/20/2014)... -- New research reveals that, long ago, sea mammals ... of the infectious disease known as tuberculosis. Ancient ... seals and sea lions, who then spread it to ... to an international team of researchers. "Tuberculosis is ... This study and further research will help us understand ...
Breaking Medicine News(10 mins):Health News:Pitt Analysis Questions Use of Acute Hemodialysis Treatment 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4Health News:'Bubble Boy' Disease May Be More Common Than Thought 2Health News:'Bubble Boy' Disease May Be More Common Than Thought 3Health News:Seals, Sea Lions Helped Global Spread of TB, Study Finds 2
(Date:8/20/2014)... , Aug. 20, 2014 /CNW/ -  Issue ... and can quickly become life threatening for some children.    ... as 1.2 million Canadians have food allergies and this number ... cent of children are estimated to have food allergies.  ... mild skin irritations and hives to breathing difficulties and loss ...
(Date:8/20/2014)... Scientists from the University of Tbingen, Arizona State University, ... and Public Health Institute (Swiss TPH) isolated Mycobacterium ... at least 1000 years old. The pathogen is a ... only occasionally causes disease in humans today. These researchers ... the Peruvian coast. "The link to sea lions was ...
(Date:8/20/2014)... visible in in this image of the Para and ... were most likely intentionally set in order to deforest ... or stand of trees where the land is thereafter ... conversion of forestland to farms, ranches, or urban use. ... of the Amazon Rainforest in the middle of the ...
Breaking Biology News(10 mins):Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3
Other Contents